E. Rutgers

发表

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Wim H van Harten, Valesca P Retel, Guido Brink, 2007, The Lancet. Oncology.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

C. Perou, E. Winer, J. Forbes, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictorss of patients 7 choices for breast conservingg therapy or mastectomy : AA prospective study

M. Sprangers, F. Oort, E. Rutgers, 2007 .

Scenario drafting to anticipate future developments in technology assessment

Valesca P Retèl, Wim H van Harten, Manuela A Joore, 2012, BMC Research Notes.

Exploring the black box of a decision aid: what information do patients select from an interactive Cd-Rom on treatment options in breast cancer?

M. Sprangers, F. Oort, E. Rutgers, 2007, Patient education and counseling.

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

J. Cuzick, J. Bergh, R. Peto, 2022, The Lancet. Oncology.

Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

T. Kühn, L. Koppert, J. French, 2022, Breast.

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group

H. Bonnefoi, E. Rutgers, P. Meijnen, 2004, Breast Cancer Research.

The contribution of routine follow‐up mammography to an early detection of asynchronous contralateral breast cancer

J. Hendriks, P. Peeters, R. Holland, 1991, Cancer.

Combined skin-sparing mastectomy and immediate implant-based breast reconstruction: Outcome following mantle field irradiation versus outcome following whole-breast irradiation.

E. Rutgers, N. Russell, L. Woerdeman, 2021, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

M. J. van de Vijver, W. V. van Harten, A. Jager, 2022, European journal of cancer.

Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers.

S. Linn, V. Retèl, E. Rutgers, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Longitudinal Serum Protein Analysis of Women with a High Risk of Developing Breast Cancer Reveals Large Interpatient Versus Small Intrapatient Variations: First Results from the TESTBREAST Study

W. Mesker, T. Luider, L. Dekker, 2022, International journal of molecular sciences.

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

H. D. de Koning, E. Heijnsdijk, M. Hooning, 2015, International journal of cancer.

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

J. Cuzick, J. Bergh, R. Peto, 2021, The Lancet. Oncology.

Association between genomic recurrence risk and well-being among breast cancer patients

W. V. van Harten, C. Groothuis-Oudshoorn, N. Aaronson, 2013, BMC Cancer.

Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study

M. Sprangers, F. Oort, E. Rutgers, 2004, British Journal of Cancer.

Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

Thomas Brüning, Kamila Czene, Ute Hamann, 2015, International journal of cancer.

Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life.

P M Bossuyt, P. Bossuyt, M. Sprangers, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follow-up care in breast cancer

E. Rutgers, 2004, Expert review of anticancer therapy.

Impact of mammographic screening on the detection of good and poor prognosis breast cancers

A. Glas, L. Esserman, S. Mook, 2011, Breast Cancer Research and Treatment.

Abstract GS4-07: Costs and effects in the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc

R. Tollenaar, E. Heijnsdijk, M. Hooning, 2020 .

Treatment decision support for early breast cancer patients

P. Bossuyt, M. Sprangers, E. Rutgers, 2007 .

Treatment decision making in breast cancer: The use of multimedia

M. Sprangers, E. Rutgers, P. Oosterveld, 1998 .

Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

H. D. de Koning, J. Klijn, R. Tollenaar, 2006, Breast Cancer Research and Treatment.

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Patients Cancer

P. Westenend, S. Siesling, A. J. Broek, 2019 .

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

M. J. van de Vijver, J. Peterse, D. Atsma, 2007, The Lancet. Oncology.

Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers

S. Linn, V. Retèl, E. Rutgers, 2009 .

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.

N. Karssemeijer, H. D. de Koning, R. Tollenaar, 2019, The Lancet. Oncology.